Trial Profile
Phase I/II Trial of Radiation Therapy and Sorafenib for Treatment of Unresectable Liver Metastases.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 11 Sep 2020
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver metastases
- Focus Adverse reactions
- Acronyms SLIM
- 08 Sep 2020 Status changed from active, no longer recruiting to completed.
- 08 Jun 2018 Planned End Date changed from 1 Nov 2017 to 1 Nov 2019.
- 08 Jun 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2019.